INDIA MEDICAL RESEARCH

Researchers work to develop a drug to treat 'GNB1 Encephalopathy' at the Indian Institute of Technology Madras

epa10388781 A researcher from the Indian Institute of Technology (IIT) Madras works inside a laboratory to develop a drug to treat 'GNB1 Encephalopathy', a rare genetic disease, in Chennai, India, 04 January 2023. The Indian Institute of Technology (IIT) Madras researchers collaborate with Tel Aviv University and Columbia University to study and develop a drug to treat 'GNB1 Encephalopathy', which is a rare genetic disease discovered by researchers a few years ago. According to Professor Amal Kanti Bera, Department of Biotechnology at IIT Madras University, 'GNB1 Encephalopathy' is a rare brain disease that is very less researched, and children born with GNB1 mutation experience mental and physical developmental delay, epilepsy (abnormal brain activity), and movement problems. This mutation affects individuals in the fetal stage. To date, less than a hundred cases have been documented worldwide. However, the actual number of affected children is probably much greater as the diagnosis is not widely available since it requires a sophisticated and expensive procedure. EPA/IDREES MOHAMMED

▶제보는 카톡 okjebo